NCT03526562View on ClinicalTrials.gov

Exercise Prescription Dose for Castration Resistance Prostate Cancer Patients

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

January 15, 2018

Primary Completion Date

June 15, 2018

Study Completion Date

June 15, 2018

Conditions
Prostatic NeoplasmsExerciseCastration-resistant Prostate CancerPhysical Activity
Interventions
BEHAVIORAL

Exercise

Exercise according to dose escalation

Trial Locations (1)

9000

University Hospital ghent, Ghent

All Listed Sponsors
lead

University Hospital, Ghent

OTHER

NCT03526562 - Exercise Prescription Dose for Castration Resistance Prostate Cancer Patients | Biotech Hunter | Biotech Hunter